For CRPC patients, PSA and PSMA mRNA expression in CTCFAPα indicated that these cells originated from the prostate tumor (Supplementary Fig. S7B), which is not unprecedented as EpCAM-/PSMA+ prostate cancer CTCs have also been identified by others.39 This evidence concerns the gene EPCAM and prostate neoplasm.